Predicting time to castration resistance in hormone sensitive prostate cancer by a personalization algorithm based on a mechanistic model integrating patient data-Reference-Cited by-同舟云学术

Predicting time to castration resistance in hormone sensitive prostate cancer by a personalization algorithm based on a mechanistic model integrating patient data

Published:2015-09-30 Issue:1 Volume:76 Page:48-57
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Elishmereni Moran¹²,Kheifetz Yuri²,Shukrun Ilan²,Bevan Graham H.³,Nandy Debashis³,McKenzie Kyle M.³,Kohli Manish³,Agur Zvia¹²

Affiliation:

1. Institute for Medical Biomathematics (IMBM); Bene Ataroth Israel

2. Optimata Ltd.; Bene Ataroth Israel

3. Mayo Clinic; Rochester Minnesota

Publisher

Wiley

Subject

Urology,Oncology

Reference19 articles.

1. Ten-year follow-up of radiation therapy oncology group protocol 92-02: A phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer;Horwitz;J Clin Oncol,2008

2. Intermittent androgen deprivation therapy in advanced prostate cancer;Alva;Curr Treat Options Oncol,2014

3. Prostate cancer progression after androgen deprivation therapy: Mechanisms of castrate resistance and novel therapeutic approaches;Karantanos;Oncogene,2013

4. Coupling a stochastic approximation version of EM with an MCMC procedure;Kuhn;ESAIM Probab Stat,2004

5. Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancer;Armstrong;Eur Urol,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Fitting the Average to Fitting the Individual: A Cautionary Tale for Mathematical Modelers;Frontiers in Oncology;2022-04-28

2. Mathematical model of hormone sensitive prostate cancer treatment using leuprolide: A small step towards personalization;PLOS ONE;2022-02-15

3. Intermittent Hormone Therapy Models Analysis and Bayesian Model Comparison for Prostate Cancer;Bulletin of Mathematical Biology;2021-11-19

4. Predicting patient-specific response to adaptive therapy in metastatic castration-resistant prostate cancer using prostate-specific antigen dynamics;Neoplasia;2021-09

5. From fitting the average to fitting the individual: A cautionary tale for mathematical modelers;2021-08-03